|
Volumn 35, Issue 7, 2003, Pages 2748-2749
|
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTIMETABOLITE;
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
DACLIZUMAB;
FRESENIUS THYMOCYTE ANTIBODY;
INSULIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
ADULT;
BACTERIAL INFECTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIALYSIS;
DIET RESTRICTION;
DRUG BLOOD LEVEL;
FEMALE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INTERMETHOD COMPARISON;
KIDNEY DONOR;
KIDNEY TRANSPLANTATION;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
MICROEMULSION;
PATIENT SELECTION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT INFECTION;
SIDE EFFECT;
URINARY TRACT INFECTION;
WOUND INFECTION;
|
EID: 0242552408
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2003.09.036 Document Type: Conference Paper |
Times cited : (7)
|
References (13)
|